Cantor Lower Price Target on Synergy (SGYP); Maintains Buy
Tweet Send to a Friend
Cantor Fitzgerald maintained a Buy rating on Synergy Pharmaceuticals (NASDAQ: SGYP) and lowered its price target to $11.00 (from $15.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE